• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$5.87 -$0.04 (-0.68%)

REAL-TIME: Last trade at

Boston Scientific Corp.

NYSE:BSX

Jump to this page for:

Related Resources

Conditions of Growth, Economic Analysis - Research Report on SandRidge Energy Inc. and Boston Scientific Corporation

5/25/2012 by Marketwire

Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews

5/25/2012 by Marketwire

Boston Scientific Presents Data During Digestive Disease Week

5/23/2012 by EndoNurse

Feeling A Little Better About The Growth/Value Proposition At Medtronic

5/22/2012 by Seeking Alpha

Catalysts That Could See Medtronic Jump After Earnings

5/21/2012 by Seeking Alpha

A less-invasive way to replace heart valves

5/20/2012 by Star Tribune - Minneapolis MN

Boston Scientific gets FDA approval for stent

5/18/2012 by Minneapolis / St. Paul Business Journal - Minneapolis MN

FDA Approval for BSX Epic Stent - Analyst Blog

5/18/2012 by Zacks Investment Research

FDA Approval for BSX Epic Stent

5/18/2012 by Zacks Equity Research Analyst Blog

Boston Scientific has a conference call hosted by JP Morgan

5/18/2012 by Theflyonthewall.com

Barclays' medical supplies and devices analysts hold a conference call

5/18/2012 by Theflyonthewall.com

Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®

5/18/2012 by StockWatch

Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®

5/18/2012 by PR Newswire

Boston Scientific (BSX) Reports Encouraging Data from PROMUS Element Study;

5/18/2012 by StreetInsider.com

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

5/18/2012 by PR Newswire

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

5/17/2012 by StockWatch

Boston Scientific announces FDA approval and market launch of Epic Stent System

5/17/2012 by Theflyonthewall.com

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

5/17/2012 by PR Newswire

Leerink's medical supplies and devices analysts hold a conference call

5/17/2012 by Theflyonthewall.com

BSX Unveils Positive Data at EuroPCR - Analyst Blog

5/16/2012 by Zacks Investment Research

BSX Unveils Positive Data at EuroPCR

5/16/2012 by Zacks Equity Research Analyst Blog

Global Cables and Leads for Medical Equipment Industry

5/16/2012 by PR Newswire

Boston Scientific Innova Has CE Mark - Analyst Blog

5/15/2012 by Zacks Investment Research

Boston Scientific Innova Has CE Mark

5/15/2012 by Zacks Equity Research Analyst Blog

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety and Effectiveness Data of the Boston Scientific SYNERGY(tm) Stent Versus Promus Element(tm) Platinum Chromium Stent

5/15/2012 by StockHouse

Boston Scientific (BSX): Trial Suggests Lotus Aortic Valve System Minimizes Aortic Regurgitation

5/15/2012 by iStockAnalyst

Boston Scientific announces trial results confirm effectiveness of SYNERGY stent

5/15/2012 by Theflyonthewall.com

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

5/15/2012 by PR Newswire

Boston Scientific (BSX) Reports Encouraging Data from REPRISE I Feasibility

5/15/2012 by StreetInsider.com

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

5/15/2012 by PR Newswire

Boston Scientific says REPRISE I feasibility trial data positive

5/15/2012 by Theflyonthewall.com

Medical device groups 'fail to innovate'

5/14/2012 by FT.com

Appaloosa liquidates stake in Boston Scientific

5/14/2012 by Theflyonthewall.com

Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering

5/14/2012 by StockWatch

Boston Scientific (BSX), Philips (PHG) Enter Imaging Equipment Sales Agreement

5/14/2012 by StreetInsider.com

Boston Scientific anti-stroke device performs well in study

5/12/2012 by Boston Herald - Boston MA

BSX Presentation at EuroPCR - Analyst Blog

5/11/2012 by NASDAQ

BSX Presentation at EuroPCR - Analyst Blog

5/11/2012 by Zacks Investment Research

BSX Presentation at EuroPCR

5/11/2012 by Zacks Equity Research Analyst Blog

Leerink's medical supplies and devices analyst hosts a luncheon meeting

5/11/2012 by Theflyonthewall.com
See More Articles...